India calls for partnership with Switzerland in R&D, biotechnology, pharmaceuticals, therapeutics

20 Feb 2026 Evaluate

With an aim to further strengthen economic ties, India called for increased collaboration in research and development (R&D), biotechnology, specialty pharmaceuticals, and advanced therapeutics with Switzerland.  In a meeting with President of the Swiss Confederation Guy Parmelin, the Commerce and Industry Minister, Piyush Goyal, called for Swiss investments in sectors where Switzerland has established niche technological strengths. 

During the meeting, both parties acknowledged the importance of balancing innovation with responsibility in the context of AI and highlighted that TEPA presents valuable opportunities for technological collaboration in fields such as precision engineering, health sciences, renewable energy, innovation and research and development. 

Last year, India and the European Free Trade Association (EFTA) implemented the trade and economic partnership agreement (TEPA). EFTA members are Iceland, Liechtenstein, Norway, and Switzerland. Goyal mentioned ‘The Agreement opens doors for 'Make in India' products to integrate into the $1 trillion market of Switzerland. From farmers and fishermen to forest dwellers, workers, women, youth, small businesses, and professionals, TEPA has opened doors to new opportunities and a brighter economic future.’ TEPA aims to facilitate investments of $100 billion into India and support the creation of one million direct jobs.

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×